XML 73 R34.htm IDEA: XBRL DOCUMENT v2.4.1.9
Business segment information (Tables)
3 Months Ended
Mar. 29, 2015
Segment Reporting [Abstract]  
Segment Results
The following tables present the Company’s segment results for the three months ended March 29, 2015 and March 30, 2014:
 
Three Months Ended
 
March 29, 2015
 
March 30, 2014
 
(Dollars in thousands)
Revenue
 
 
 
Vascular North America
$
67,913

 
$
62,506

Anesthesia/Respiratory North America
55,390

 
54,714

Surgical North America
38,059

 
35,231

EMEA
129,282

 
150,245

Asia
48,529

 
49,602

OEM
34,715

 
33,182

All other
55,542

 
53,066

Consolidated net revenues
$
429,430

 
$
438,546

 
 
 
Three Months Ended
 
March 29, 2015
 
March 30, 2014
 
(Dollars in thousands)
Operating profit
 
 
 
Vascular North America
$
12,702

 
$
9,392

Anesthesia/Respiratory North America
7,752

 
5,687

Surgical North America
12,327

 
10,548

EMEA
26,335

 
26,881

Asia
8,146

 
12,837

OEM
8,043

 
6,604

All other
8,349

 
9,768

Total segment operating profit (1)
83,654

 
81,717

Unallocated expenses (2)
(18,046
)
 
(22,697
)
Income from continuing operations before interest and taxes
$
65,608

 
$
59,020

(1)
Segment operating profit includes segment net revenues from external customers reduced by its standard cost of goods sold, adjusted for fixed manufacturing cost absorption variances, selling, general and administrative expenses, research and development expenses and an allocation of corporate expenses. Corporate expenses are allocated among the segments in proportion to the respective amounts of one of several items (such as sales, numbers of employees, and amount of time spent), depending on the category of expense involved.
(2)
Unallocated expenses primarily include manufacturing variances, with the exception of fixed manufacturing cost absorption variances, and restructuring and impairment charges.
 
 
Three Months Ended
 
March 29, 2015
 
March 30, 2014
 
(Dollars in thousands)
Depreciation and amortization
 
 
 
Vascular North America
$
8,477

 
$
7,855

Anesthesia/Respiratory North America
3,195

 
4,428

Surgical North America
2,478

 
2,369

EMEA
7,898

 
8,937

Asia
2,398

 
1,838

OEM
1,667

 
1,456

All other
3,737

 
4,530

Consolidated depreciation and amortization
$
29,850

 
$
31,413

Schedule of Revenues and Property Plant Equipment by Geographic Region
The following table provides total net revenues for the three months ended March 29, 2015 and March 30, 2014 and total net property, plant and equipment by geographic region as of March 29, 2015 and December 31, 2014:
 
Three Months Ended
 
March 29, 2015
 
March 30, 2014
 
(Dollars in thousands)
Net revenue (based on selling location)
 
 
 
United States
$
231,206

 
$
216,461

Other Americas
13,441

 
14,771

Europe
140,682

 
168,775

All other
44,101

 
38,539

 
$
429,430

 
$
438,546

Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country
 
March 29, 2015
 
December 31, 2014
 
(Dollars in thousands)
Net property, plant and equipment
 
 
 
United States
$
177,431

 
$
174,893

Malaysia
36,173

 
36,427

Czech Republic
32,541

 
35,655

All other
63,961

 
70,460

 
$
310,106

 
$
317,435